BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 29, 2014
View Archived Issues
Investors hear the call, back biotechs developing ear drugs
Last month, two companies developing drugs for the ear – a fairly neglected field – went public.
Read More
Week in review
Read More
Word on the street
Read More
Week in Washington
Read More
FDA approvals in August
Read More
Phase I clinical trials update: August 2014
Read More
Phase II clinical trials update: August 2014
Read More
Phase III clinical trials update: August 2014
Read More
Pharma clinical and FDA action update: August 2014
Read More
Non-U.S. clinical trials and regulatory actions: August 2014
Read More
FDA submissions, approvals & other actions: August 2014
Read More
Money raised by biotech in 2014 vs. 2013
Read More
Money raised by biotech: Jan. 1 - Sept. 25, 2014
Read More
The week's biggest gainers and losers
Read More
BioWorld stock report for public biotechnology companies
Read More